Moreover, further analysis suggested that methylation level changes of ACE2 promoter and the dynamics of TF‐ACE2 regulatory networks could be responsible for the expression difference of ACE2 between tumours and controls (Figure 1G,H, P < 0.05). Here, ACE2 is linked to neoplasm.